PLXNB2 and central nervous system cancer: The mechanism of EGCG+HC may be through the downregulation of SEMA3A and SEMA3F transcript expression which may play some roles in inhibiting the glioma proliferation and halts invasion via Plexin A1 (PLXNA1) and B2 (PLXNB2) receptors.